Bone Cancer SymptomsSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Bone Cancer Symptoms Biography

Source(google.com.pk)
Caring.com User - Melanie Haiken
Send a Hug or Prayer
See full bio
96% helpful
Melanie Haiken answered...
Bone cancer can have many different signs and symptoms because there are several types of bone cancer. There is cancer that originates in the bone, called primary bone cancer, and See also:
What are the signs of bone cancer?

See all 1930 questions about Cancer there are tumors that spreads, or metastasizes, from other locations such as the breast, lungs, or prostate, to the bone. This is called metastatic or secondary bone cancer. Primary bone cancer is very rare (only 2500 cases per year) and is more common among children and young adults, but secondary bone cancer is more common among older adults. Multiple myeloma and leukemia are cancers of the bone marrow, the cells within bone that produce blood, so they have different symptoms.

The most common symptom of bone cancer is pain. Bone cancer pain is different than other types of pain because it may worsen at night, or during or after physical activity. It also tends to remain constant, unlike joint or muscle pain that you’d expect to wax and wane. Other signs of bone cancer include:

    A lump
    Tenderness in one spot
    Swelling
    An unexpected fracture because the bone is weakened
    Anemia
    Fever and chills
    Weight loss
If you’re concerned about possible bone cancer, ask your doctor to order scans and blood tests. It’s particularly important to insist on tets if you are battling cancer in another area of your body or are a cancer survivor. If tests indicate possible cancer, a bone biopsy may be performed.

Other signs reported by bone cancer patients:

Some of the early signs of bone cancer may be confused with arthritis and other conditions. Some bone cancer patients report:

Bone Cancer Symptoms

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Bone Cancer Symptoms

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Bone Cancer Symptoms

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Bone Cancer Symptoms

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Bone Cancer Symptoms

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Bone Cancer Symptoms

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Bone Cancer Symptoms

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Bone Cancer Symptoms

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Bone Cancer Symptoms

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Bone Cancer Symptoms

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Bone Cancer Symptoms

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 

 

 

 

 

 

 

 

 

 

 

Gallbladder CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Gallbladder Cancer Biography

Source(google.com.pk)

Bile from the liver is funneled into the gallbladder by way of the cystic duct. Between meals, the gallbladder stores a large amount of bile. To do this, it must absorb much of the water and electrolytes from the bile. In fact, the inner surface of the gallbladder is the most absorptive surface in the body. After a meal, the gallbladder's muscular walls contract to deliver the bile back through the cystic duct and eventually into the small intestine, where the bile can help digest food.
Demographics

About 5, 000 people are diagnosed with gallbladder cancer each year in the United States, making it the fifth most common gastrointestinal cancer. It is more common in females than males and most patients are elderly. Southwest American Indians have a particularly high incidence—6 times that of the general population.
Causes and symptoms

Gallstones are the most significant risk factor for the development of gallbladder cancer. Roughly 75 to 90 percent of patients with gallbladder cancer also have gallstones. Larger gallstones are associated with a higher chance of developing gallbladder cancer. Chronic inflammation of the gallbladder from infection also increases the risk for gallbladder cancer.

Unfortunately, sometimes cancer of the gallbladder does not produce symptoms until late in the disease. When symptoms are evident, the most common is pain in the upper right portion of the abdomen, underneath the right ribcage. Patients with gallbladder cancer may also report symptoms such as nausea, vomiting, weakness, jaundice, skin itching , fever , chills, poor appetite, and weight loss .
Diagnosis

Gallbladder cancer is often misdiagnosed because it mimics other more common conditions, such as gallstones, cholecystitis, and pancreatitis. But the imaging tests that are utilized to evaluate these other conditions can also detect gallbladder cancer. For example, ultrasound is a quick, noninvasive imaging test that reliably diagnoses gallstones and cholecystitis. It can also detect the presence of gallbladder cancer as well as show how far the cancer has spread. If cancer is suspected, a computed tomography scan is useful in confirming the presence of an abnormal mass and further demonstrating the size and extent of the tumor. Cholangiography, usually performed to evaluate a patient with jaundice, can also detect gallbladder cancer.

There are no specific laboratory tests for gallbladder cancer. Tumors can obstruct the normal flow of bile from the liver to the small intestine. Bilirubin, a component of bile, builds up within the liver and is absorbed into the bloodstream in excess amounts. This can be detected in a blood test, but it can also manifest clinically as jaundice. Elevated bilirubin levels and clinical jaundice can also occur with other conditions, such as gallstones.

On occasion, gallbladder cancer is diagnosed incidentally. About one percent of all patients who have their gallbladder removed for symptomatic gallstones are found to have gallbladder cancer. The cancer is found either by the surgeon or by the pathologist who inspects the gallbladder with a microscope.
Treatment team

The main member of the treatment team is the surgeon, since surgical removal of the cancer is the only measure that offers a significant chance of cure. Sometimes the cancer is too advanced such that surgery would be of no benefit. But the patient might suffer from jaundice or blockage of the stomach. In this case, the gastroenterologist or interventional radiologist may be able to provide non-surgical alternatives to address these complications. In limited scenarios, the oncologist or radiation therapist may treat the patient with chemotherapy or radiation therapy .
Clinical staging, treatments, and prognosis

Staging of gallbladder cancer is determined by the how far the cancer has spread. The effectiveness of treatment declines as the stage progresses. Stage I cancer is confined to the wall of the gallbladder. Approximately 25% of cancers are at this stage at the time of diagnosis. Stage II cancer has penetrated the full thickness of the wall, but has not spread to nearby lymph nodes or invaded adjacent organs. Stage III cancer has spread to nearby lymph nodes or has invaded the liver, stomach, colon, small intestine, or large intestine. Stage IV disease has invaded very deeply into two or more adjacent organs or has spread to distant lymph nodes or organs by way of metastasis .

Early Stage I cancers involving only the innermost layer of the gallbladder wall can be cured by simple removal of the gallbladder. Cancers at this stage are sometimes found incidentally when the gallbladder is removed in the treatment of gallstones or cholecystitis. The majority of patients have good survival rates. Late Stage I cancers, which involve the outer muscular layers of the gallbladder wall, are generally treated in the same way as Stage II or III cancers. Removal of the gallbladder is not sufficient forthese stages. The surgeon also removes nearby lymph nodes as well as a portion of the adjacent liver (radical surgery). Survival rates for these patients are considerably worse than for those with early Stage I disease. Patients with early Stage IV disease may benefit from radical surgery, but the issue is controversial. Late Stage IV cancer has spread too extensively to allow complete excision. Surgery is not an option for these patients.

Gallbladder Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Gallbladder Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Gallbladder Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Gallbladder Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Gallbladder Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Gallbladder Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Gallbladder Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Gallbladder Cancer 

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Gallbladder Cancer 

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Gallbladder Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 

                                   Gallbladder Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 

 

 

 

 

 

 

 

 

 

 

 

Metastatic CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Metastatic Cancer Biography

Source(google.com.pk)

Bio-Nucleonics, Inc., a life sciences Company, specializing in the development and manufacture of radiopharmaceuticals, medical devices and imaging agents, will be attending the Society of Nuclear Medicine (SNM) Annual Meeting, held in San Antonio, TX, June 4th through 8th, 2011.

The Company announced that it has resumed production of the cancer drug Strontium Chloride Sr-89 Injection USP ("Strontium-89"). Strontium-89 is an intravenously administered cancer drug that provides long lasting pain relief for patients suffering from bone pain due to metastatic cancer, typically caused by advanced stage breast, prostate or lung cancer.

Strontium-89 is preferentially absorbed in bone metastases, providing a long-term effect resulting in an enhanced quality-of-life. There are approximately 300,000 new cases per year in the U.S., an area of unmet medical need. It has been reported that there is a decrease in pain, an increase in physical activity and a reduction in the need for opiate analgesics, such as morphine, in up to 80% of patients.

President and Chief Executive Officer Roseanne Satz stated, "Our participation at SNM is crucial to meeting with our radiopharmacy customers and creating market awareness. The exposure and introductions gained from these industry conferences yield opportunities that advance our future growth. We are pleased to be able to fill the demand for this important drug which allows greater flexibility in pain management and improves patient quality-of-life."

 Metastatic Cancer 

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Metastatic Cancer 

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Metastatic Cancer 

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Metastatic Cancer 

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Metastatic Cancer 

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Metastatic Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Metastatic Cancer 

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Metastatic Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Metastatic Cancer 

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Metastatic Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 

 Metastatic Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 

 

 

 

 

 

 

 

 

 

 

Cancer InstitudSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer Insitud Biography

Source(google.com.pk)

Harold Varmus, M.D., co-recipient of a Nobel Prize for studies of the genetic basis of cancer, was nominated by President Obama as Director of the National Cancer Institute on May 17, 2010. He began his tenure as NCI Director on July 12, 2010. He previously served as President and Chief Executive Officer of Memorial Sloan-Kettering Cancer Center Exit Disclaimer (MSKCC) and as Director of the National Institutes of Health (NIH).

Much of Varmus' scientific work was conducted during 23 years as a faculty member at the University of California, San Francisco, Medical School, where he and Dr. J. Michael Bishop and their co-workers demonstrated the cellular origins of the oncogene of a chicken retrovirus. This discovery led to the isolation of many cellular genes that normally control growth and development and are frequently mutated in human cancer. For this work, Bishop and Varmus received many awards, including the 1989 Nobel Prize for Physiology or Medicine. Varmus is also widely recognized for his studies of the replication cycles of retroviruses and hepatitis B viruses, the functions of genes implicated in cancer, and the development of mouse models of human cancer (the focus of much of the work in his laboratory at MSKCC).

In 1993, Varmus was named by President Clinton to serve as the Director of NIH, a position he held until the end of 1999. During his tenure at NIH, he initiated many changes in the conduct of intramural and extramural research programs; recruited new leaders for most of the important positions at NIH; planned three major buildings on the NIH campus, including the Mark O. Hatfield Clinical Research Center ; and helped to initiate the five-year doubling of the NIH budget.

At MSKCC, Varmus emphasized opportunities to harness advances in the biological sciences to improve the care of patients with cancer. Under his leadership, the scientific programs were reorganized and enlarged; a new research building, the Mortimer B. Zuckerman Research Center, was constructed; and new graduate training programs were established in chemical biology and computational biology (as part of a new Tri-Institutional Research Program with Rockefeller University and Weill-Cornell Medical College) and in cancer biology (through MSKCC's first degree-awarding program in the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences).

In addition, he oversaw the construction of new clinical facilities (for pediatrics, pathology, urology, and surgery) and new centers for breast cancer treatment and imaging Exit Disclaimer (the Evelyn H. Lauder Breast Center and the MSKCC Imaging Center); the founding of a hospital-based program in translational research (the Human Oncology and Pathogenesis Program Exit Disclaimer); and the development of the Tri-Institutional Stem Cell Initiative and the Starr Cancer Consortium, involving five research institutions. To ensure that MSKCC was promoting high-quality cancer care for all citizens of New York and equal opportunities for its employees, he helped to found and oversee a new cancer clinic in central Harlem (the Ralph Lauren Center for Cancer Care and Prevention) and new programs for diversity and gender equity (the Office of Diversity Programs in Clinical Care, Research, and Training and the Women Faculty Affairs Program).

Varmus has authored over 300 scientific papers and five books, including an introduction to the genetic basis of cancer for a general audience and a memoir, The Art and Politics of Science, published in 2009. He has been an advisor to the Federal government, pharmaceutical and biotechnology firms, and many academic institutions, and was appointed by President Barack Obama as co-chair of the President's Council of Advisors on Science and Technology (PCAST). He served on the World Health Organization's Commission on Macroeconomics and Health from 2000 to 2002; is a co-founder and Chairman of the Board of Directors of the Public Library of Science, a publisher of open-access journals in the biomedical sciences; chaired the Scientific Board of the Grand Challenges in Global Health at the Bill and Melinda Gates Foundation from 2003 to 2008 and now chairs the Foundation's Global Health Advisory Committee; and is involved in several initiatives to promote science in developing countries, including the Global Science Corps, through the Science Initiatives Group. He was also a member of the Funding Committee of the Empire State Stem Cell Board and serves as co-chair of the Institute of Medicine's committee on "The U.S. Commitment to Global Health." He has been a member of the U.S. National Academy of Sciences Exit Disclaimer since 1984 and of the Institute of Medicine Exit Disclaimer since 1991, and has received the National Medal of Science, the Vannevar Bush Award, and several honorary degrees and other prizes, in addition to the Nobel Prize.

A native of Freeport, Long Island, Varmus is the son of Dr. Frank Varmus, a general practitioner, and Beatrice Varmus, a psychiatric social worker. After graduating from Freeport High School, he majored in English literature at Amherst College and earned a master's degree in English at Harvard University. He is a graduate of Columbia University's College of Physicians and Surgeons, worked as a medical student in a hospital in India, and served on the medical house staff at Columbia-Presbyterian Medical Center. He began his scientific training as a Public Health Service officer at NIH, where he studied bacterial gene expression with Dr. Ira Pastan, and then trained as a post-doctoral fellow with Dr. Bishop at the University of California, San Francisco.

Cancer Insitud

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer Insitud 

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer Insitud

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer Insitud

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer Insitud

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer Insitud

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer Insitud

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer Insitud

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer Insitud

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer Insitud

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer Insitud

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 

 

 

 

 

 

 

 

 

 

 

 

Brain CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Brain Cancer Biography

Source(google.com.pk)
Genentech BioOncology is dedicated to advancing the science of glioblastoma therapy through comprehensive research programs and education. Glioblastomas usually form in astrocytes in the cerebral white matter.1
Glioblastoma Demographic Statistics

    In 2004–2007, an estimated 37,890 Americans were diagnosed with glioblastoma—16.7% of all reported brain tumors2

    Most brain tumors are not associated with known risk factors.1 However, risk factors include ionizing radiation exposure to the head and a family history of inherited conditions such as neurofibromatosis type 1 and Li-Fraumeni syndrome1,3
    The 5-year survival rate for patients with glioblastoma is 2.9%4
    The median survival time for glioblastoma is limited to approximately 10 to 15 months5

Symptoms of glioblastoma include headache; nausea; vomiting; blurred vision; balance problems; drowsiness; seizure; hemiparesis; and progressive memory, personality, or neurologic deficits.1,3
Other links to glioblastoma disease information

These links give a sampling of other sites offering information on glioblastoma, which you may find useful in your practice.

    National Cancer Institute at National Institutes of Health, Brain Tumor
    ASCO Cancer Portals - Head & Neck Cancers
    Cancer Facts & Figures

Unless otherwise indicated, Genentech, Inc. is neither affiliated with nor endorses any of the organizations listed.

    American Cancer Society. Brain and spinal cord tumors in adults. www.cancer.org/Cancer/BrainCNSTumorsinAdults/DetailedGuide/brain-and-spinal-cord-tumors-in-adults-what-is-cancer. Accessed April 14, 2011.

    CBTRUS (2011). CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2007. Source: Central Brain Tumor Registry of the United States, Hinsdale, IL. Web site: www.cbtrus.org. Accessed April 13, 2011.

    US Department of Health and Human Services. National Cancer Institute. What you need to know about™ brain tumors. Accessed April 14, 2011.

    Barnholtz-Sloan JS, Sloan AE, Schwartz AG. Cancer of the brain and other central nervous system. In: SEER Survival Monograph. National Cancer Institute. www.seer.cancer.gov/publications/survival/surv_brain.pdf. Accessed April 14, 2011.

    Nieder C, Grosu AL, Astner S, Molls M. Treatment of unresectable glioblastoma multiforme. Anticancer Res. 2005;25:4605-4610. PMID: 16334150 

Brain Cancer 

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Brain Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Brain Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Brain Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Brain Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Brain Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Brain Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Brain Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Brain Cancer 

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Brain Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Brain Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos